Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonists
Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1 R)-hydroxyethyl] and a 2′-hydroxy group. Due to restricted rotation of the phenyl–pyridine bond, these analogues exist as four isomers. A diastereo...
Saved in:
Published in | Bioorganic & medicinal chemistry letters Vol. 12; no. 23; pp. 3421 - 3424 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Elsevier Ltd
02.12.2002
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1
R)-hydroxyethyl] and a 2′-hydroxy group. Due to restricted rotation of the phenyl–pyridine bond, these analogues exist as four isomers. A diastereoselective methylcopper reaction was developed to facilitate the synthesis, and single isomers were isolated with activities in the range IC
50=10–25 nM.
Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1
R)-hydroxyethyl] and a 2′-hydroxy group. Due to restricted rotation of the phenyl–pyridine bond, these analogues exist as four isomers. A diastereoselective methylcopper reaction was developed to facilitate the synthesis, and single isomers were isolated with activities in the range IC
50=10–25 nM. |
---|---|
AbstractList | Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1
R)-hydroxyethyl] and a 2′-hydroxy group. Due to restricted rotation of the phenyl–pyridine bond, these analogues exist as four isomers. A diastereoselective methylcopper reaction was developed to facilitate the synthesis, and single isomers were isolated with activities in the range IC
50=10–25 nM.
Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1
R)-hydroxyethyl] and a 2′-hydroxy group. Due to restricted rotation of the phenyl–pyridine bond, these analogues exist as four isomers. A diastereoselective methylcopper reaction was developed to facilitate the synthesis, and single isomers were isolated with activities in the range IC
50=10–25 nM. Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1R)-hydroxyethyl] and a 2'-hydroxy group. Due to restricted rotation of the phenyl-pyridine bond, these analogues exist as four isomers. A diastereoselective methylcopper reaction was developed to facilitate the synthesis, and single isomers were isolated with activities in the range IC(50)=10-25 nM. |
Author | Cook, James H. Osterhout, Martin H. Shao, Chunning Korpusik, Mary Schoen, William R. Livingston, James N. Romero, Romulo H. Hertzog, Donald L. Smith, Roger A. Ladouceur, Gaetan H. Hundertmark, Thomas Lease, Timothy G. Jones, J.Howard MacDougall, Margit L. Phelan, Kathleen |
Author_xml | – sequence: 1 givenname: Gaetan H. surname: Ladouceur fullname: Ladouceur, Gaetan H. email: gaetan.ladouceur.b@bayer.com organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA – sequence: 2 givenname: James H. surname: Cook fullname: Cook, James H. organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA – sequence: 3 givenname: Donald L. surname: Hertzog fullname: Hertzog, Donald L. organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA – sequence: 4 givenname: J.Howard surname: Jones fullname: Jones, J.Howard organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA – sequence: 5 givenname: Thomas surname: Hundertmark fullname: Hundertmark, Thomas organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA – sequence: 6 givenname: Mary surname: Korpusik fullname: Korpusik, Mary organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA – sequence: 7 givenname: Timothy G. surname: Lease fullname: Lease, Timothy G. organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA – sequence: 8 givenname: James N. surname: Livingston fullname: Livingston, James N. organization: Department of Metabolic Disorders Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA – sequence: 9 givenname: Margit L. surname: MacDougall fullname: MacDougall, Margit L. organization: Department of Metabolic Disorders Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA – sequence: 10 givenname: Martin H. surname: Osterhout fullname: Osterhout, Martin H. organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA – sequence: 11 givenname: Kathleen surname: Phelan fullname: Phelan, Kathleen organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA – sequence: 12 givenname: Romulo H. surname: Romero fullname: Romero, Romulo H. organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA – sequence: 13 givenname: William R. surname: Schoen fullname: Schoen, William R. organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA – sequence: 14 givenname: Chunning surname: Shao fullname: Shao, Chunning organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA – sequence: 15 givenname: Roger A. surname: Smith fullname: Smith, Roger A. organization: Department of Chemistry Research, Bayer Research Center, 400 Morgan Lane, West Haven, CT 06516, USA |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14493149$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/12419375$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkMFq3DAQhkVISTZpHiFFl0JzcDuyJHt1KiG0SSDQQ1voTcjyaKPilYwkB7ZPXzu7JMecBobv_5n5zshxiAEJuWTwmQFrvvwE1UC1VuLPJ6ivAFreVOqIrJhoRMUFyGOyekFOyVnOfwGYACFOyCmrBVO8lStS7kPBTTLFx0Cjo3Esfuv_YU_z1OXiy4Sh0NGUgilkWiIdU-wni_TRbx6HHR1jWQhRmbQbqnGXfO8D0s0wWbOZOxNaHEtM1ISyLHwu-T1558yQ8eIwz8nv799-3dxVDz9u72-uHyrLFS-VtMCFRSWsNNw0NUrZKZxfU73o1hIaqVpnG-fWqpNGCd45aFlr1wZqU9eOnxO577Up5pzQ6TH57XyoZqAXi_rZol4Uaaj1s0Wt5tyHfW6cui32r6mDthn4eABMtmZwyQTr8ysnhOJMLEVf9xzOXz55TDpbj8Fi72cvRffRv3HKf54OlBg |
CitedBy_id | crossref_primary_10_1016_j_bmc_2005_10_008 crossref_primary_10_1002_adsc_201300211 crossref_primary_10_1002_chin_200312132 crossref_primary_10_4155_fmc_13_13 crossref_primary_10_1070_RC2008v077n12ABEH003783 crossref_primary_10_1210_er_2006_0026 crossref_primary_10_1517_13543776_15_12_1739 crossref_primary_10_1016_j_bmcl_2006_11_014 crossref_primary_10_1021_jm300579z |
Cites_doi | 10.1016/S0065-7743(08)60581-3 10.1074/jbc.274.13.8694 10.1016/S0065-7743(08)61086-6 10.1016/0196-9781(89)90010-7 10.1056/NEJM198106183042504 10.1056/NEJM197505082921901 10.1016/S0960-894X(01)00766-1 10.1016/S0960-894X(02)00143-9 10.1021/jm9810304 10.1016/0304-4157(94)00015-6 10.1016/0026-0495(78)90291-3 10.1517/13543776.9.6.701 10.1016/S1367-5931(00)00103-4 10.1002/(SICI)1096-9136(199712)14:5+3.3.CO;2-I 10.1146/annurev.bi.60.070191.003253 10.1039/b001971m |
ContentType | Journal Article |
Copyright | 2002 Elsevier Science Ltd 2003 INIST-CNRS |
Copyright_xml | – notice: 2002 Elsevier Science Ltd – notice: 2003 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION |
DOI | 10.1016/S0960-894X(02)00736-9 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Chemistry |
EISSN | 1464-3405 |
EndPage | 3424 |
ExternalDocumentID | 10_1016_S0960_894X_02_00736_9 12419375 14493149 S0960894X02007369 |
Genre | Journal Article |
GroupedDBID | --- --K --M .HR .~1 0R~ 1B1 1RT 1~. 1~5 23N 4.4 457 4G. 53G 5GY 5VS 6TJ 7-5 71M 8P~ 9JM 9JN AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARLI AATCM AAXUO ABBQC ABFNM ABGSF ABJNI ABLVK ABMAC ABMZM ABTAH ABUDA ABXDB ABYKQ ABZDS ACDAQ ACGFS ACIUM ACNNM ACRLP ADBBV ADECG ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AENEX AFFNX AFKWA AFTJW AFXIZ AFZHZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJSZI ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 D0L DOVZS EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FLBIZ FNPLU FYGXN G-2 G-Q GBLVA HEA HMK HMO HMS HMT HVGLF HZ~ IHE J1W KOM LCYCR LZ2 M29 M2Z M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SCB SCC SDF SDG SDP SES SEW SOC SPC SPCBC SPT SSH SSK SSP SSU SSZ T5K WUQ XFK XPP Y6R YK3 ZMT ZY4 ~02 ~G- ABPIF ABPTK IQODW AAXKI AKRWK CGR CUY CVF ECM EIF NPM AAYXX AFJKZ CITATION |
ID | FETCH-LOGICAL-c393t-5c034ce94c5a3a62e55b9e4059d4b8506597fc6ff89b5a943bf0717c8a02a22f3 |
IEDL.DBID | .~1 |
ISSN | 0960-894X |
IngestDate | Thu Sep 26 18:55:57 EDT 2024 Sat Sep 28 08:38:11 EDT 2024 Sun Oct 22 16:09:36 EDT 2023 Fri Feb 23 02:33:04 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 23 |
Keywords | Pancreatic hormone Glucagon Halophenols Nitrogen heterocycle Peptide hormone Non peptide compound Non insulin dependent diabetes In vitro Pyridine derivatives Hypoglycemic agent Structure activity relation Phenols Peptidergic receptor Benzenic compound Antagonist Fluorine Organic compounds Chemical synthesis Diastereomer |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c393t-5c034ce94c5a3a62e55b9e4059d4b8506597fc6ff89b5a943bf0717c8a02a22f3 |
PMID | 12419375 |
PageCount | 4 |
ParticipantIDs | crossref_primary_10_1016_S0960_894X_02_00736_9 pubmed_primary_12419375 pascalfrancis_primary_14493149 elsevier_sciencedirect_doi_10_1016_S0960_894X_02_00736_9 |
PublicationCentury | 2000 |
PublicationDate | 2002-12-02 |
PublicationDateYYYYMMDD | 2002-12-02 |
PublicationDate_xml | – month: 12 year: 2002 text: 2002-12-02 day: 02 |
PublicationDecade | 2000 |
PublicationPlace | Oxford |
PublicationPlace_xml | – name: Oxford – name: England |
PublicationTitle | Bioorganic & medicinal chemistry letters |
PublicationTitleAlternate | Bioorg Med Chem Lett |
PublicationYear | 2002 |
Publisher | Elsevier Ltd Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
References | Dohlman, Thorner, Caron, Lefkowitz, Christophe, Unger, Orci, Gerich, Lorenzi, Bier, Schneider, Tsalikian, Karam, Forsham, Unger (BIB3) 1991; 60 Livingston, Schoen, Connell, Cascieri, Koch, Ber, Sadowski, Louizides, De Laszlo, Hacker, Hagmann, MacCoss, Chicchi, Vicario, Madsen, Knudsen, Wiberg, Carr (BIB5) 1999; 34 BIB9 Smith, Hertzog, Osterhout, Ladouceur, Korpusik, Bobko, Jones, Phelan, Romero, Hundertmark, MacDougall, Livingston, Schoen (BIB7) 2002; 12 BIB16 BIB17 Amos, McCarty, Zimmet (BIB1) 1997; 14 Sato, Kobayashi, Takahashi, Chiba, Takeda, Kusakabe (BIB11) 1985; 1636 Lloyd-Williams, Giralt (BIB8) 2001; 30 Ladouceur, Cook, Doherty, Schoen, MacDougall, Livingston, Schoen, Ladouceur, Cook, Lease, Wolanin, Kramss, Hertzog, Osterhout (BIB6) 2002; 12 BIB12 BIB13 BIB14 BIB15 Zhang, Moller, Cobb, Dukes (BIB2) 2000; 4 BIB10 Unson, Gurzenda, Merrifield, Salzig, Unson, Merrifield (BIB4) 1989; 10 Ladouceur (10.1016/S0960-894X(02)00736-9_BIB6_1) 2002; 12 Amos (10.1016/S0960-894X(02)00736-9_BIB1) 1997; 14 Zhang (10.1016/S0960-894X(02)00736-9_BIB2_1) 2000; 4 Smith (10.1016/S0960-894X(02)00736-9_BIB7) 2002; 12 Gerich (10.1016/S0960-894X(02)00736-9_BIB3_4) 1975; 292 Lloyd-Williams (10.1016/S0960-894X(02)00736-9_BIB8) 2001; 30 Schoen (10.1016/S0960-894X(02)00736-9_BIB6_2) 2001; 134 Unger (10.1016/S0960-894X(02)00736-9_BIB3_5) 1978; 27 Unger (10.1016/S0960-894X(02)00736-9_BIB3_3) 1981 Dohlman (10.1016/S0960-894X(02)00736-9_BIB3_1) 1991; 60 Cascieri (10.1016/S0960-894X(02)00736-9_BIB5_3) 1999; 274 Madsen (10.1016/S0960-894X(02)00736-9_BIB5_4) 1998; 41 Connell (10.1016/S0960-894X(02)00736-9_BIB5_2) 1999; 9 Cobb (10.1016/S0960-894X(02)00736-9_BIB2_2) 1998; 33 Livingston (10.1016/S0960-894X(02)00736-9_BIB5_1) 1999; 34 Salzig (10.1016/S0960-894X(02)00736-9_BIB4_2) 1996; 45 Christophe (10.1016/S0960-894X(02)00736-9_BIB3_2) 1995; 1241 Sato (10.1016/S0960-894X(02)00736-9_BIB11) 1985; 1636 Unson (10.1016/S0960-894X(02)00736-9_BIB4_1) 1989; 10 |
References_xml | – volume: 60 start-page: 653 year: 1991 ident: BIB3 publication-title: Annu. Rev. Biochem. contributor: fullname: Unger – ident: BIB9 – volume: 1636 year: 1985 ident: BIB11 publication-title: J. Chem. Soc. Comm. contributor: fullname: Kusakabe – volume: 4 start-page: 461 year: 2000 ident: BIB2 publication-title: Curr. Opin. Chem. Biol. contributor: fullname: Dukes – volume: 12 start-page: 1303 year: 2002 ident: BIB7 publication-title: Bioorg. Med. Chem. Lett. contributor: fullname: Schoen – ident: BIB10 – ident: BIB13 – volume: 34 start-page: 189 year: 1999 ident: BIB5 publication-title: Annu. Rep. Med. Chem. contributor: fullname: Carr – ident: BIB12 – volume: 10 start-page: 1171 year: 1989 ident: BIB4 publication-title: Peptides contributor: fullname: Merrifield – volume: 30 start-page: 145 year: 2001 ident: BIB8 publication-title: Chem. Soc. Rev. contributor: fullname: Giralt – ident: BIB17 – volume: 12 start-page: 461 year: 2002 ident: BIB6 article-title: US Patent 6,218,431, 2001 publication-title: Bioorg. Med. Chem. Lett. contributor: fullname: Osterhout – ident: BIB16 – ident: BIB14 – ident: BIB15 – volume: 14, year: 1997 ident: BIB1 publication-title: Diabetic Med. contributor: fullname: Zimmet – volume: 34 start-page: 189 year: 1999 ident: 10.1016/S0960-894X(02)00736-9_BIB5_1 publication-title: Annu. Rep. Med. Chem. doi: 10.1016/S0065-7743(08)60581-3 contributor: fullname: Livingston – volume: 274 start-page: 8694 year: 1999 ident: 10.1016/S0960-894X(02)00736-9_BIB5_3 publication-title: J. Biol. Chem. doi: 10.1074/jbc.274.13.8694 contributor: fullname: Cascieri – volume: 33 start-page: 213 year: 1998 ident: 10.1016/S0960-894X(02)00736-9_BIB2_2 publication-title: Annu. Rep. Med. Chem. doi: 10.1016/S0065-7743(08)61086-6 contributor: fullname: Cobb – volume: 10 start-page: 1171 year: 1989 ident: 10.1016/S0960-894X(02)00736-9_BIB4_1 publication-title: Peptides doi: 10.1016/0196-9781(89)90010-7 contributor: fullname: Unson – start-page: 1518 year: 1981 ident: 10.1016/S0960-894X(02)00736-9_BIB3_3 publication-title: N. Engl. J. Med. doi: 10.1056/NEJM198106183042504 contributor: fullname: Unger – volume: 292 start-page: 985 year: 1975 ident: 10.1016/S0960-894X(02)00736-9_BIB3_4 publication-title: New Engl. J. Med. doi: 10.1056/NEJM197505082921901 contributor: fullname: Gerich – volume: 12 start-page: 461 year: 2002 ident: 10.1016/S0960-894X(02)00736-9_BIB6_1 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/S0960-894X(01)00766-1 contributor: fullname: Ladouceur – volume: 12 start-page: 1303 year: 2002 ident: 10.1016/S0960-894X(02)00736-9_BIB7 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/S0960-894X(02)00143-9 contributor: fullname: Smith – volume: 41 start-page: 5150 year: 1998 ident: 10.1016/S0960-894X(02)00736-9_BIB5_4 publication-title: J. Med. Chem. doi: 10.1021/jm9810304 contributor: fullname: Madsen – volume: 1241 start-page: 45 year: 1995 ident: 10.1016/S0960-894X(02)00736-9_BIB3_2 publication-title: Biochim. Biophys. Acta doi: 10.1016/0304-4157(94)00015-6 contributor: fullname: Christophe – volume: 134 start-page: 311111 year: 2001 ident: 10.1016/S0960-894X(02)00736-9_BIB6_2 article-title: US Patent 6,218,431, 2001 publication-title: Chem. Abstr. contributor: fullname: Schoen – volume: 45 start-page: 220 year: 1996 ident: 10.1016/S0960-894X(02)00736-9_BIB4_2 publication-title: Diabetes contributor: fullname: Salzig – volume: 27 start-page: 1691 year: 1978 ident: 10.1016/S0960-894X(02)00736-9_BIB3_5 publication-title: Metabolism doi: 10.1016/0026-0495(78)90291-3 contributor: fullname: Unger – volume: 9 start-page: 701 year: 1999 ident: 10.1016/S0960-894X(02)00736-9_BIB5_2 publication-title: Exp. Opin. Ther. Pat doi: 10.1517/13543776.9.6.701 contributor: fullname: Connell – volume: 4 start-page: 461 year: 2000 ident: 10.1016/S0960-894X(02)00736-9_BIB2_1 publication-title: Curr. Opin. Chem. Biol. doi: 10.1016/S1367-5931(00)00103-4 contributor: fullname: Zhang – volume: 14, year: 1997 ident: 10.1016/S0960-894X(02)00736-9_BIB1 publication-title: Diabetic Med. doi: 10.1002/(SICI)1096-9136(199712)14:5+3.3.CO;2-I contributor: fullname: Amos – volume: 60 start-page: 653 year: 1991 ident: 10.1016/S0960-894X(02)00736-9_BIB3_1 publication-title: Annu. Rev. Biochem. doi: 10.1146/annurev.bi.60.070191.003253 contributor: fullname: Dohlman – volume: 30 start-page: 145 year: 2001 ident: 10.1016/S0960-894X(02)00736-9_BIB8 publication-title: Chem. Soc. Rev. doi: 10.1039/b001971m contributor: fullname: Lloyd-Williams – volume: 1636 year: 1985 ident: 10.1016/S0960-894X(02)00736-9_BIB11 publication-title: J. Chem. Soc. Comm. contributor: fullname: Sato |
SSID | ssj0014044 |
Score | 1.7997946 |
Snippet | Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a 3-[(1... Optimized substituent patterns in 4-aryl-pyridine glucagon receptor antagonists were merged to produce highly potent derivatives containing both a... |
SourceID | crossref pubmed pascalfrancis elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 3421 |
SubjectTerms | Benzyl Compounds - chemistry Benzyl Compounds - pharmacology Biological and medical sciences General and cellular metabolism. Vitamins Inhibitory Concentration 50 Medical sciences Pharmacology. Drug treatments Pyridines - chemistry Pyridines - pharmacology Receptors, Glucagon - antagonists & inhibitors Stereoisomerism Structure-Activity Relationship |
Title | Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonists |
URI | https://dx.doi.org/10.1016/S0960-894X(02)00736-9 https://www.ncbi.nlm.nih.gov/pubmed/12419375 |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CAmmhhHbTR5J20aGE9KCsVw_HOi5LwyYlubSBvRlJlspCYptd97A55LdnJNtZEiiFXmU9zMx4HvLMNwBfJS_cWNsiYIYaKtjYUI1eAU0K5pUU2vBYHn11nc5uxOVczrdg2tfChLTKTve3Oj1q625k1FFzVC8Wo5_B-c6UmCfhuo2noYhPoPlDmT59eErzCOgxEUIKJ9Mwe1PF0-4QB08S9i1uQtXf7NObWq-Qar5td_HCCY3G6Pwt7HVeJJm0L_oOtlw5gP1JiRH03Zock5jXGS_MB_Bq2vd0G8DuVfcrfR-aiw4oAhlDKk8q1B13i3tXkBXqkpBAgOaI1BF-s1yRpiJ1BId1JCAc365JXTVhhqB6ub6l9Xq5QDPoSMiB179xTySrqzGiJ8i7MICvsHoPN-fff01ntGvBQC1XvKHSJlxYp4SVmuuUOSmNcujkqUKYAHaH8Yi3qfeZMlIrwY0PAaLNdMI0Y55_gO2yKt0nIIVKUckza84SK_CzVyYTbuy54WOLYqEO4LQnfF63SBv5JgUNOZUHTuUJyyOnclyQ9ezJn4lMjtbgX0uHz9i5OVAIxTFoPICPLX83T9DVQVdOHv7_qUfwuu8lk7DPsN0s_7gv6NI0Zhhldgg7k4sfs-tHtWDzOw |
link.rule.ids | 315,783,787,4509,24128,27936,27937,45597,45691 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlEkhGALtDyKDwjBwd2sHyE-ViuqLXR7oZX2ZtmOjVZqk2g3PSwHfjtjJ2FVJITE1fEjmpnMfHbG3wC8k7z0E-PKyBlqqWATSw2iApqVLCgpjOXpevT8Ip9diS8LudiB6XAXJqZV9r6_8-nJW_ct416a42a5HH-L4LtQYpHF4zaeq3twX0R8jEZ9_PN3nkekj0kcUtibxu7bazzdFKnxQ8Y-plmo-luAetSYNYotdPUu_kChKRqdPoHHPYwkJ92bPoUdX41g_6TCLfTNhrwnKbEznZiPYG86FHUbwYN5_y99H9qznikCNUPqQGp0HjfLH74ka3QmMYMA4xFpEv9mtSZtTZrEDutJpDi-3pCmbmMPQc1qc02bzWqJcdCTmARvvuOcKFff4JaeoPJiA77C-hlcnX6-nM5oX4OBOq54S6XLuHBeCScNNznzUlrlEeWpUtjIdocCDy4PoVBWGiW4DXGH6AqTMcNY4M9ht6orfwCkVDl6eebsp8wJ_O6VLYSfBG75xKFdqEM4HgSvm45qQ29z0FBTOmpKZ0wnTWkcUAzq0XdsRmM4-NfQozvq3C4ohOK4azyEF51-t08Q6yCWky__f9W3sDe7nJ_r87OLr6_g4VBYJmOvYbdd3fo3iG9ae5Ts9xdl2_TU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Integration+of+optimized+substituent+patterns+to+produce+highly+potent+4-aryl-pyridine+glucagon+receptor+antagonists&rft.jtitle=Bioorganic+%26+medicinal+chemistry+letters&rft.au=Ladouceur%2C+Gaetan+H.&rft.au=Cook%2C+James+H.&rft.au=Hertzog%2C+Donald+L.&rft.au=Jones%2C+J.Howard&rft.date=2002-12-02&rft.pub=Elsevier+Ltd&rft.issn=0960-894X&rft.eissn=1464-3405&rft.volume=12&rft.issue=23&rft.spage=3421&rft.epage=3424&rft_id=info:doi/10.1016%2FS0960-894X%2802%2900736-9&rft.externalDocID=S0960894X02007369 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-894X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-894X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-894X&client=summon |